Look for:

Our offer for

MODERNA INC.


ISIN:
US60770K1079
WKN:
60770K107

2020/11/27 19:00:00
Price
127.03 USD
Difference 16.35% (17.85)

General attributes

ISINUS60770K1079
SymbolMRNA
ExchangeNasdaq
CurrencyUSD
SectorChemical / Pharmaceutical / Health
Security typeStock
Market cap (m)42,204 EUR
BenchmarkS&P 500

Market data

Bid (Bid size)128.15 USD (200)
Ask (Ask size)128.40 USD (100)
Open115.12 USD
High130.06 USD
Low114.86 USD
Close (prev. day)109.18 USD
VWAP124.452132 USD
Volume (pcs)43,438,495
Trading volume5,404,171,468.00
Number of trades396,218
Last size143,250

Futures and Options

Related Futures-
Related Options-

PDF Downloads

Annual report: MODERNA INC.PDF Download

Scale: ABS REL         Instrument

Add Benchmark:



Information about previous performance does not guarantee future performance.
Source: FactSet

Recent research



2020/11/27 19:00:00
Price
127.03 USD
Difference 16.35% (17.85)

General attributes

ISINUS60770K1079
SymbolMRNA
ExchangeNasdaq
CurrencyUSD
SectorChemical / Pharmaceutical / Health
Security typeStock
Market cap (m)42,204 EUR
BenchmarkS&P 500

Market data

Bid (Bid size)128.15 USD (200)
Ask (Ask size)128.40 USD (100)
Open115.12 USD
High130.06 USD
Low114.86 USD
Close (prev. day)109.18 USD
VWAP124.452132 USD
Volume (pcs)43,438,495
Trading volume5,404,171,468.00
Number of trades396,218
Last size143,250

Performance and Risk

6M1Y3Y
Perf (%)+58.23%+445.90%-
Perf (abs.)+40.18+89.18-
Beta0.600.070.32
Volatility77.9393.9780.56
Scale: ABS REL         Instrument

Add Benchmark:



Information about previous performance does not guarantee future performance.
Source: FactSet

Price data

Ø price 5 days | Ø volume 5 days (pcs.)99.83 USD (17,206,794)
Ø price 30 days | Ø volume 30 days (pcs.)79.65 USD (12,837,901)
Ø price 100 days | Ø volume 100 days (pcs.)73.42 USD (16,224,067)
Ø price 250 days | Ø volume 250 days (pcs.)51.46 USD (15,333,262)
YTD High | date109.29 USD (2020/11/25)
YTD Low | date17.68 USD (2020/01/07)
52 Weeks High | date109.29 USD (2020/11/25)
52 Weeks Low | date17.68 USD (2020/01/07)

All listings for MODERNA INC.

Exchange  DateTimePriceTrading volume (mio.)Number of trades
Xetra2020/11/2717:37104.30 EUR7.21864
Tradegate2020/11/2722:26107.06 EUR43.584,248
Stuttgart2020/11/2721:54107.38 EUR4.08284
Nasdaq2020/11/2719:00127.03 USD5,404.17396,218
Munich2020/11/2719:42106.18 EUR0.6660
London Stock Exchange2020/11/2718:14126.2000 USD1.25354
Hanover2020/11/2718:46105.82 EUR0.0412
Hamburg2020/11/2719:28106.52 EUR0.1625
Frankfurt2020/11/2719:55106.20 EUR5.80718
Duesseldorf2020/11/2719:30106.20 EUR0.1638
Berlin2020/11/2719:36106.60 EUR0.9561

Company Logo

https://gateway.mdgms.com/extern/logo_image.html?ID_LOGO=144067&ID_TYPE_IMAGE_LOGO=2

Contact Details

MODERNA INC.
Lavina Talukdar
Technology Square 200 02139 Cambridge, Massachusetts
Telefon: +1-617-714-6500
Fax: +1-617-583-1998
E-mail: IR@modernatx.com

PDF Downloads

Annual report: MODERNA INC.PDF Download

Company Profile

Moderna is advancing messenger RNA (mRNA) science to create a new class of transformative medicines for patients. mRNA medicines are designed to direct the body's cells to produce intracellular, membrane or secreted proteins that can have a therapeutic or preventive benefit and have the potential to address a broad spectrum of diseases. Moderna's platform builds on continuous advances in basic and applied mRNA science, delivery technology and manufacturing, providing the Company the capability to pursue in parallel a robust pipeline of new development candidates. Moderna is developing therapeutics and vaccines for infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune and inflammatory diseases, independently and with strategic collaborators.

Members of Management Board

Noubar AfeyanChairman of Board of Directors
Stephen BerensonMember of Board of Directors
Sandra Horning, M.D.Member of Board of Directors
Robert LangerMember of Board of Directors
Paul SaganMember of Board of Directors
François Nader, M.D.Member of Board of Directors
Elizabeth TallettMember of Board of Directors
Stéphane BancelChairman of Managing Board
Tracey FranklinMember of Executive Committee
Stephen Hoge, M.D.Member of Executive Committee
Ray JordanMember of Executive Committee
Marcello DamianiMember of Executive Committee
Lori HendersonMember of Executive Committee
Juan AndresMember of Executive Committee
David MelineMember of Executive Committee
Tal ZaksMember of Executive Committee






Accept

We use cookies and web analysis software to give you the best possible experience on our website. By continuing to browse this website, you consent for these tools to be used. For more details and how to opt out of these, please read our Data protection policy.

INFORMATION FOR PRIVATE CLIENTS / CONSUMERS

Any information, material and services regarding financial instruments and securities provided by Erste Group Bank AG or any of its affiliates (collectively “Erste Group“) on this and any linked website hereafter (jointly the “Websites”) shall be exclusively to investors who are not subject to any legal sale or purchase restrictions (the “Interested Party“).

The publication and distribution of information as well as offering and selling of products and services described on the Websites is prohibited by law in some jurisdictions. For this reason, persons in countries in which the publication as well as the offering and selling of products and services described on the Websites are not permitted by law, must not enter the Websites and/or acquire the products displayed on the Websites.

Neither Erste Group nor any third party shall offer access to the Websites or offer the products to especially, but not limited to citizen/residents of the United States and “U.S. person” (as defined in Regulation S under the US Securities Act 1933 as amended). For this reason, the distribution or redistribution of the information, materials and products into United States or into any other jurisdiction where it is not permitted under the applicable law, as well as to the citizens/residents of these countries shall be prohibited. The securities displayed on the Websites have not been and will not be registered under the US Securities Act of 1933 and trading in the securities has not been approved for purposes of the US Commodities Exchange Act of 1936. For this reason the securities may, inter alia, not be offered, sold or delivered within the United States or, for the account and benefit of U.S. persons.

The Interested Party is solely responsible to examine, whether he may enter the Websites under the law applicable to it. Erste Group shall not be responsible for the distribution of content of any of the Websites to individuals or entities which provide false information about their right to enter the Websites. For this reason Erste Group shall not be liable for any legal claims or damages which may result from the unauthorized entering or reading of the Websites.

By agreeing to this hereto, the Interested Party confirms that
(i) It has read, understood and accepted this Information and the Disclaimer;
(ii) It informed itself about any possible legal restriction and warrants that it is not restricted or prohibited to enter the Websites according to any law applicable; and
(iii) It does not make available the contents of the Websites to any person who is not qualified by law to enter the Websites.